'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies.
Central Core Disease
Centronuclear myopathy
Congenital Myopathy
Dusty Core Disease
RYR1 recessive
Ryanodine receptor
Journal
Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673
Informations de publication
Date de publication:
05 01 2019
05 01 2019
Historique:
received:
19
12
2018
accepted:
21
12
2018
entrez:
7
1
2019
pubmed:
7
1
2019
medline:
3
4
2020
Statut:
epublish
Résumé
Several morphological phenotypes have been associated to RYR1-recessive myopathies. We recharacterized the RYR1-recessive morphological spectrum by a large monocentric study performed on 54 muscle biopsies from a large cohort of 48 genetically confirmed patients, using histoenzymology, immunohistochemistry, and ultrastructural studies. We also analysed the level of RyR1 expression in patients' muscle biopsies. We defined "dusty cores" the irregular areas of myofibrillar disorganisation characterised by a reddish-purple granular material deposition with uneven oxidative stain and devoid of ATPase activity, which represent the characteristic lesion in muscle biopsy in 54% of patients. We named Dusty Core Disease (DuCD) the corresponding entity of congenital myopathy. Dusty cores had peculiar histological and ultrastructural characteristics compared to the other core diseases. DuCD muscle biopsies also showed nuclear centralization and type1 fibre predominance. Dusty cores were not observed in other core myopathies and centronuclear myopathies. The other morphological groups in our cohort of patients were: Central Core (CCD: 21%), Core-Rod (C&R:15%) and Type1 predominance "plus" (T1P+:10%). DuCD group was associated to an earlier disease onset, a more severe clinical phenotype and a lowest level of RyR1 expression in muscle, compared to the other groups. Variants located in the bridge solenoid and the pore domains were more frequent in DuCD patients. In conclusion, DuCD is the most frequent histopathological presentation of RYR1-recessive myopathies. Dusty cores represent the unifying morphological lesion among the DuCD pathology spectrum and are the morphological hallmark for the recessive form of disease.
Identifiants
pubmed: 30611313
doi: 10.1186/s40478-018-0655-5
pii: 10.1186/s40478-018-0655-5
pmc: PMC6320585
doi:
Substances chimiques
RYR1 protein, human
0
Ryanodine Receptor Calcium Release Channel
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3Subventions
Organisme : Sapienza Università di Roma
ID : RM116154C9D1415B
Pays : International
Références
Neuropathol Appl Neurobiol. 2011 Apr;37(3):271-84
pubmed: 21062345
Hum Mutat. 2012 Jun;33(6):981-8
pubmed: 22473935
Neurology. 2005 Dec 27;65(12):1930-5
pubmed: 16380615
J Neurol. 2013 Jun;260(6):1504-10
pubmed: 23329375
Neuromuscul Disord. 2009 May;19(5):344-7
pubmed: 19303294
Hum Mutat. 2010 Jul;31(7):E1544-50
pubmed: 20583297
Bioinformatics. 2014 Oct 15;30(20):2981-2
pubmed: 24996895
JAMA Ophthalmol. 2013 Dec;131(12):1532-40
pubmed: 24091937
Am J Med Genet A. 2012 Apr;158A(4):772-8
pubmed: 22407809
Ann Neurol. 2010 Nov;68(5):717-26
pubmed: 20839240
Handb Clin Neurol. 2013;113:1321-36
pubmed: 23622357
Brain. 2007 Aug;130(Pt 8):2024-36
pubmed: 17483490
Neurology. 2013 Apr 23;80(17):1584-9
pubmed: 23553484
Acta Neuropathol. 2017 Apr;133(4):517-533
pubmed: 28012042
Hum Gene Ther. 2013 Jul;24(7):702-13
pubmed: 23805838
Neuromuscul Disord. 2013 Jul;23(7):540-8
pubmed: 23628358
Hum Mutat. 2008 May;29(5):670-8
pubmed: 18253926
Hum Mol Genet. 2003 May 15;12(10):1171-8
pubmed: 12719381
Neuromuscul Disord. 2009 Oct;19(10):721-9
pubmed: 19683444
Hum Mol Genet. 2006 Sep 15;15(18):2791-803
pubmed: 16940308
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1149-52
pubmed: 24828896
Orphanet J Rare Dis. 2007 Jul 13;2:31
pubmed: 17631035
Muscle Nerve. 2011 Jul;44(1):102-8
pubmed: 21674524
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Orphanet J Rare Dis. 2013 Aug 06;8:117
pubmed: 23919265
Eur J Neurol. 2015 Jul;22(7):1094-112
pubmed: 25960145
J Neuromuscul Dis. 2015 Nov 20;2(4):421-432
pubmed: 27858745
Neuromuscul Disord. 2010 Apr;20(4):223-8
pubmed: 20181480
Brain. 2003 Nov;126(Pt 11):2341-9
pubmed: 12937085
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2270-4
pubmed: 8134386
Eur J Med Genet. 2011 Jan-Feb;54(1):29-33
pubmed: 20888934
Nucleic Acids Res. 2015 Jul 1;43(W1):W174-81
pubmed: 25883148
Neuromuscul Disord. 2017 Nov;27(11):975-985
pubmed: 28818389
Neurology. 2002 Jul 23;59(2):284-7
pubmed: 12136074
Cell. 2016 Sep 22;167(1):145-157.e17
pubmed: 27662087
Neuromuscul Disord. 2016 Sep;26(9):624-33
pubmed: 27377473
Acta Neuropathol Commun. 2016 Nov 17;4(1):121
pubmed: 27855725
Hum Mol Genet. 2000 Nov 1;9(18):2599-608
pubmed: 11063719
Neurology. 2000 Dec 12;55(11):1689-96
pubmed: 11113224
Cell Res. 2016 Sep;26(9):995-1006
pubmed: 27468892
Ann Neurol. 2002 Jun;51(6):750-9
pubmed: 12112081